electED.

HR 124 · 119th Congress — Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [ sic ] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to…

Congress
119
Bill
HR 124
Status
Introduced
Introduced
2025-01-03
Latest action date
2025-01-03

Summary

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [ sic ] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

This summary may describe an earlier version. Check the official record for current wording.

Latest action

Referred to the House Committee on Energy and Commerce.

Sponsors

Sources